10.1002/cmdc.201700453
ChemMedChem
FULL PAPER
[23] Y. Imamura, T. Mukohara, Y. Shimono, Y. Funakoshi, N. Chayahara, M.
Toyoda, N. Kiyota, S. Takao, S. Kono, T. Nakatsura, H. Minami, Oncol.
Rep. 2015, 33, 1837-43.
The biological studies were performed in Toxicology Research
Laboratory, CePT, Mossakowski Medical Research Centre. LC
and MS analysis were done in Laboratory of Chemical Synthesis,
CePT, Mossakowski Medical Research Centre, both established
within the project co-financed by EU from the European
Regional Development Fund under the Operational Programme
Innovative Economy, 2007-2013.
[24] D. Loessner, K.S. Stok, M.P. Lutolf, D.W. Hutmacher, J.A. Clements,
S.C. Rizzi, Biomaterials 2010, 31, 8494-506.
[25] A.F. Adcock, G. Trivedi, R. Edmondson, C. Spearman, L. Yang, J. Anal.
Bioanal. Tech. 2015, 6, 247.
[26] Z. Wen, Q. Liao, Y. Hu, L. You, L. Zhou, Y. Zhao, Braz. J. Med. Biol.
Res. 2013, 46, 634-42.
[27] O. Trédan, C.M. Galmarini, K. Patel, I.F. Tannock, J. Natl. Cancer Inst.
2007, 99, 1441-54.
The article presents research results generated by the project
"New gastro-resistant medicine fighting the side effects of
opioids", no. POIG.01.04.00-14-213/12, co-financed by the
European Union under the European Regional Development
Funds.
[28] D. Brossard, L.E. Kihel, M. M. Clement, W. Sebbahi, M. Khalid, C.
Roussakis, S. Rault, Eur. J. Med. Chem. 2010, 45, 2912-8.
[29] B. Morak-Młodawska, K. Pluta, M. Latocha, M. Jeleń, D. Kuśmierz, J.
Enzyme Inhib. Med. Chem. 2016, 31, 1132-8.
[30] E. Rutkowska, K. Pajak, K. Jóźwiak, Acta Pol. Pharm. 2013, 70, 3-18.
[31] K. Gupta, S. Kshirsagar, L. Chang, R. Schwartz, P.Y. Law, D. Yee, R.P.
Hebbel, Cancer Res. 2002, 62, 4491–4498.
Keywords: pancreatic cancer • peptidomimetics • spheroids •
opioid receptors • anticancer drugs
[32] I. Tegeder, S. Grosch, A. Schmidtko, A. Haussler, H. Schmidt, E.
Niederberger, K. Scholich, G. Geisslinger, Cancer Res. 2003, 63,
1846–1852.
References:
[33] M.P. Yeager, T.A. Colacchio, Arch. Surg. 1991, 126, 454–456.
[34] G. Li, P.S. Low, Bioorg. Med. Chem. Lett. 2017, 27, 2074-2078.
[35] F. Cheng, P.J McLaughlin, M.F. Verderame, I.S. Zagon, Mol. Cancer
2008, 7, 5.
[1]
T.Conroy, J.B. Bachet, A. Ayav, F. Huguet, A. Lambert, C. Caramella,
R. Maréchal, J.L. Van Laethem, M. Ducreux, Eur. J. Cancer 2016, 57,
10-22.
[36] P.J. McLaughlin, I.S. Zagon, Biochem. Pharmacol. 2012, 84, 746-55.
[37] J. Fichna, J.C. do-Rego, P. Kosson, P.W. Schiller, J. Costentin, A.
Janecka, Biochem. Biophys. Res. Commun. 2006, 345, 162-8.
[2]
[3]
[4]
[5]
[6]
M. Falasca, M. Kim, I. Casari, Biochim. Biophys. Acta 2016, 1865, 123-
32.
R. Tugyi, K., Uray, D. Ivan, E. Fellinger, A. Perkins, F. Hudecz, PNAS
2005, 102, 413-418.
D. Knappe, P. Henklein, R. Hoffman, K. Hilpert, Antimicrob. Agents
Chemother. 2010, 54, 4003-4005.
L. Gentilucci, R. De Marco, L. Cerisoli, Curr. Pharm. Des. 2010, 16,
3185-203.
I.S. Zagon, J.R. Jaglowski, M.F. Verderame, J.P. Smith, A.E. Leure-
Dupree, P.J. McLaughlin, Cancer Chemother. Pharmacol. 2005, 56,
510-20.
[7]
[8]
G. Gopalakrishnan, S. Lepetre, A. Maksimenko, S. Mura, D. Desmaële,
P. Couvreur, Adv. Healthc. Mater. 2015, 4, 1015-22.
S. Horvat, K. Mlinarić-Majerski, L. Glavas-Obrovac, A. Jakas, J.
Veljković, S. Marczi, G. Kragol, M. Roscić, M. Matković, A. Milostić-Srb,
J. Med. Chem. 2006, 49, 3136-42.
[9]
M. Lazarczyk, E. Matyja, A.W. Lipkowski, Peptides 2010, 31, 1606-12.
[10] P. De, M. Baltas, F. Bedos-Belval, Curr. Med. Chem. 2011, 18, 1672-
703.
[11] J. Kornhuber, A.W. Henkel, T.W. Groemer, S. Städtler, O. Welzel, P.
Tripal, A. Rotter, S. Bleich, S. Trapp, J. Cell. Physiol. 2010, 224, 152-64.
[12] A.W. Lipkowski (Mossakowski Medical Research Centre, Polish
Academy of Sciences, Warsaw), Polish Pat. Appl. WO 2014102571A1,
2014.
[13] A.W. Lipkowski, A. Misicka, P. Davis, D. Stropova, J. Janders, M.
Lachwa, F. Porreca, H.I. Yamamura, V.J. Hruby, Bioorg. Med. Chem.
Lett. 1999, 9, 2763-6.
[14] A. Knopik-Skrocka, J. Bielawski, Biol. Lett. 2005, 42, 49–60.
[15] ASTM E2524-08, Standard Test Method for Analysis of Hemolytic
Properties of Nanoparticles, ASTM International, West Conshohocken,
PA, 2013.
[16] D.B. Longley, D.P. Harkin, P.G. Johnston, Nat. Rev. Cancer, 2003, 5,
330-8.
[17] L. de Sousa Cavalcante, G. Monteiro, Eur. J. Pharmacol. 2014, 741, 8-
16.
[18] P.H. Jiang, Y. Motoo, N. Sawabu, T. Minamoto, World J. Gastroenterol.
2006, 12, 1597-602.
[19] R. Edmondson, J. Jenkins Broglie, A. F. Adcock, L. Yang, Assay Drug
Dev. Technol. 2014, 12, 207–218.
[20] A.I. Minchinton, I.F. Tannock, Nat. Rev. Cancer. 2006, 6, 583-592.
[21] M. Gredicak, F. Supek, M. Kralj, Z. Majer, M. Hollósi, T. Smuc, K.
Mlinarić-Majerski, S. Horvat, Amino Acids 2010, 38, 1185-91.
[22] H. van de Waterbeemd, H. Karajiannis, N. El Tayar, Amino Acids 1994,
7, 129-45.
8
This article is protected by copyright. All rights reserved.